Mirum (MIRM) Director Sells $397,700 in Company Stock
Published on Β· Source: investing.com
AI Summary
Summarized by AI from the source belowSaira Ramasastry, a director at Mirum Pharmaceuticals (MIRM), sold $397,700 worth of company stock. The transaction may indicate changes in insider sentiment regarding the company's future. Insider selling can influence market perception and investor confidence. Such sales could lead to fluctuations in MIRM's stock price, depending on investor reaction to these insider movements.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
